Genetic Microdevices Ltd has developed a disruptive technology that analyses proteins and DNA with ultra-high performance. The instrument is based on a disposable analysis chip. Protein and DNA analysis are central to any biological analysis including drug development, research and diagnostics. Our device encompasses unique intellectual property which makes it far more potent than directly competing analytical devices. A key feature of the technology is that it performs the advanced analysis using a disposable microfluidic cartridge that can separate biological molecules with unprecedented sensitivity and resolution.
Looking for a particular Genetic Microdevices Ltd employee's phone or email?
The Genetic Microdevices Ltd annual revenue was $5 million in 2026.
Dimitrios Sideris is the CEO of Genetic Microdevices Ltd.
4 people are employed at Genetic Microdevices Ltd.
The NAICS codes for Genetic Microdevices Ltd are [541, 54, 541713, 54171, 5417].
The SIC codes for Genetic Microdevices Ltd are [873, 87].